View Older Stories View More Recent Stories

Feb 14, 2019 05:16PM Form SC 13G TG THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:16PM Form SC 13G ARVINAS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:16PM Form SC 13G Orchard Therapeutics Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:16PM Form SC 13G Myovant Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:16PM Form SC 13G Crinetics Pharmaceutical Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:15PM Form SC 13G/A InflaRx N.V. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:15PM Form SC 13G/A Kadmon Holdings, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:15PM Form SC 13G ZOGENIX, INC. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:15PM Form SC 13G/A Spero Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:15PM Form SC 13G/A BIOCRYST PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:15PM Form SC 13G/A Biohaven Pharmaceutical Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:14PM Form SC 13G/A Krystal Biotech, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:01PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31

Feb 14, 2019 02:00AM Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia

Feb 11, 2019 04:52PM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 11, 2019 04:51PM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, LLC

Jan 28, 2019 04:34PM Form 4 Wave Life Sciences Ltd. For: Jan 24 Filed by: RA CAPITAL MANAGEMENT, LLC

Jan 28, 2019 04:33PM Form SC 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, LLC

Jan 23, 2019 08:38AM PlacementTracker Publishes 2018 PIPE and Private Placement Markets League Tables

Jan 9, 2019 10:37PM Black Diamond Therapeutics Closes $85 Million Series B Financing

Jan 7, 2019 08:00AM Apple Tree Partners Announces Partner and Team Promotions

Jan 3, 2019 07:30AM Sojournix Completes $44 Million Series C Financing

Dec 18, 2018 07:00AM Stoke Therapeutics Expands Senior Leadership Team, Adding Deep Expertise in Regulatory Affairs and Clinical Operations

Dec 17, 2018 06:15AM Form SC 13D Synthorx, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC

Dec 13, 2018 06:31PM Form 4 Synthorx, Inc. For: Dec 11 Filed by: RA CAPITAL MANAGEMENT, LLC

Dec 11, 2018 08:00AM WhiteSwell Announces $30 Million Financing for New Therapeutic Approach to Acute Decompensated Heart Failure

Dec 6, 2018 06:58PM Form 3 Synthorx, Inc. For: Dec 06 Filed by: RA CAPITAL MANAGEMENT, LLC

Dec 1, 2018 01:00PM Stoke Therapeutics Presents Data Showing Single Dose of ASO Therapy Restores Normal Protein Levels in Animal Model of Genetic Epilepsy

Nov 29, 2018 12:00AM ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes

Nov 27, 2018 09:00AM Stoke Therapeutics to Present New Data on Lead Program at American Epilepsy Society's 2018 Annual Meeting

Nov 14, 2018 04:32PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Sep 30

Nov 7, 2018 06:14AM Form SC 13D/A Dicerna Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC

Nov 2, 2018 06:05AM Form SC 13D/A Dicerna Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC

Nov 1, 2018 08:02PM Form 4 Ra Pharmaceuticals, Inc. For: Nov 01 Filed by: RA CAPITAL MANAGEMENT, LLC

Oct 25, 2018 05:20PM Form SC 13G Eiger BioPharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC

Oct 25, 2018 07:53AM 89Bio Launches into Liver and Metabolic Disorders with $60 Million Series A Financing

Oct 23, 2018 08:38AM PlacementTracker Publishes Q3 2018 Private Placement Market League Tables

Oct 5, 2018 04:34PM Form SC 13D/A Kala Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, LLC

Sep 26, 2018 09:16PM Form 3 ARVINAS HOLDING COMPANY, For: Sep 26 Filed by: RA CAPITAL MANAGEMENT, LLC

Sep 26, 2018 07:00AM Lyra Therapeutics Announces $29.5 Million Series B Financing to Advance Innovative Therapeutics for Ear, Nose and Throat Diseases

Sep 12, 2018 08:00AM The Arizona Bioscience Company of the Year is on a Mission to Cure the Uncurable

Sep 5, 2018 12:46PM TeraPore Technologies Unveils New Nanofiltration Membrane Technology at BioProcess International Conference

Aug 14, 2018 04:38PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Jun 30

Aug 13, 2018 09:05AM Ivantis Announces FDA Approval for Its Innovative Hydrus® Microstent Device for Minimally Invasive Glaucoma Surgery (MIGS)

Aug 13, 2018 04:00AM Orchard Therapeutics Announces $150 Million Series C Financing to Advance Gene Therapy Pipeline

Aug 7, 2018 07:00AM Akouos Raises $50 Million Series A Financing and Expands Team to Advance Precision Genetic Therapies That Restore and Preserve Hearing

Aug 6, 2018 04:31PM Form SC 13G/A BIOCRYST PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC

Jul 24, 2018 12:44PM Biopharmaceutical Industry Veteran Marty Siwak joins TeraPore Technologies as Chief Commercial Officer

Jul 19, 2018 08:38AM PlacementTracker Publishes First Half 2018 PIPE Market League Tables

Jul 11, 2018 08:00PM Mitra RxDx Announces $40 Million Financing Round

View More Recent Stories View Older Stories